5 sources checked · 2 source groups included · 1h ago
Still Watching
FDA approves breakthrough drug to treat advanced pancreatic cancer
CBS News and WLWT Cincinnati (Hearst) describe the same event in different terms.
1 Left4 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 27, 2026 at 2:51 AM, this is how Optics News reads the wording differences in this story.
What happenedThe Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer.
The headline splitThe left frames it as "FDA approves new pancreatic cancer drug that could extend patients' lives". The center frames it as "FDA approves new drug Rasonque to treat advanced pancreatic cancer".
Match confidenceMedium confidence. 5 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
5 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
64/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA approves new pancreatic cancer drug that could extend patients' lives
CBS News · Center-left · News report
CenterFDA approves breakthrough drug to treat advanced pancreatic cancer
KABC / ABC7 Los Angeles · Center · News report
Right / center-rightNo matching source in this bucket yet.
FDA approves new pancreatic cancer drug that could extend patients' lives
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
FDA approves new drug Rasonque to treat advanced pancreatic cancer
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the...
